REDHILL BIOPHARMA LTD
Market Data Charts Historical Prices Statistics Profile AnalysisAndRatios Disclosures
www.redhillbio.com
LATE CLINICAL-STAGE DEVELOPMENT AND COMMERCIALIZAION OF DRUGS FOR GASTROINTESTINAL DISEASES.
   Issuer No   
Corporate No
   Market Cap (16/06/2019)   
   1573   
   514304005   
    728,792 NIS thousands   
   TASE Supersector
   TASE Sector   
   TASE Subsector   
   Indices1   
   High-Tech   
   Biomed   
   Biotechnology   
   TA-90, TA-125, TA-Biomed Index, TA Global-BlueTech, TA-AllShare, TA Tech - Elite, TA-Rimon, TA-SME150, TA-Industrials, Additional indices   
Shares Bonds Convertible Bonds Warrants All Securities
  REDHILL  
 
Symbol:
RDHLDual-Listed Company Market Maker Appointed for Security  
ISIN: IL0011223810
Type of Security: Share
 
Tel-Aviv
As of 17/06/2019 14:28
Data is delayed by 20 min
 Last Price
(0.01 NIS)
 253.10 
 Change(%) -1.48% 
 Turnover (NIS)
 198,452 
 Trans.
 43 
 Capital Listed for Trading
 283,686,908 
 Market Cap (NIS thousands)
 728,792 
 Base Price
 256.90 
 Opening Price
 256.90 
 High
 256.90 
 Low
 251.10 
 Yield MTD (%) -3.8% 
 Yield YTD (%) 27.4% 
 Foreign Stock Exchange NASDAQ-GM 
 
 
 
Previous Trading Days - REDHIL BIOPHARM
DateClosing PriceAdjusted Closing Price*Change (%)Base PriceOpening PriceHighLowTurnover(NIS)
16/06/2019
256.90
256.90
0.27%
256.20
258
258
256.30
57,814
13/06/2019
256.20
256.20
2.11%
250.90
256.20
261.50
253.50
537,961
   Open in a Separate Window   
* Adjusted to Dividends and Benefits
Last messages from TASE - True for date 6/17/2019 - 2:48 PM Financial Statements
6/16/2019 6:44 PM
6/16/2019 6:43 PM
6/10/2019 2:59 PM
5/28/2019 1:59 PM
5/23/2019 3:01 PM
Recent Company Disclosure (Hebrew Only)
Corporate Actions (Hebrew Only)